Titolo Rivista PNEI REVIEW
Autori/Curatori
Pubblicazione Online First 17/09/2025 Fascicolo 2025/Online First
Lingua Inglese Numero pagine 10 P. 1-10 Dimensione file 0 KB
DOI 10.3280/pnei2025oa20961
Il DOI è il codice a barre della proprietà intellettuale: per saperne di più
clicca qui
FrancoAngeli è membro della Publishers International Linking Association, Inc (PILA)associazione indipendente e non profit per facilitare (attraverso i servizi tecnologici implementati da CrossRef.org) l’accesso degli studiosi ai contenuti digitali nelle pubblicazioni professionali e scientifiche
The growing body of evidence on the role of the gut microbiota (GM) in regulating the bidirectional gut-brain axis suggests the existence of a complex network that also involves the immune system (IS). The interaction between GM and IS is crucial for the development and modulation of immune responses, through microbial metabolites such as short-chain fatty acids (SCFAs), which influence both mucosal immunity and neuroinflammation. SCFAs regulate immune homeostasis and the function of the blood-brain barrier (BBB), affecting microglia, astrocytes, and neurons. These mechanisms are particularly relevant in neurological disorders such as Parkinson’s disease, where dysbiosis and SCFA alterations contribute to neurodegeneration. Although most results derive from preclinical studies and should be interpreted with caution, the use of probiotics, prebiotics, and postbiotics represents a promising therapeutic approach. The “microbiota-immune-brain” model opens new insights for the prevention and treatment of neurological and psychiatric disorders, although larger and more specific clinical trials are needed to confirm its applicability in humans.
, The microbiota-immune interaction in the gut-brain axis in "PNEI REVIEW" Online First/2025, pp 1-10, DOI: 10.3280/pnei2025oa20961